Aachen Resonance enters the booming Indian Healthcare Market
2
Aachen Resonance GmbH Pauwelsstrasse 19, 52074 Aachen, Tel. +49-(0)241-97900905, Fax +49-(0)241- 97900907, E-Mail: [email protected] Aachen, Germany, 07.01.2009 Aachen Resonance enters the booming Indian Healthcare Market with its new developed polymer-free Drug eluting Stent Communication: Aachen Resonance announces the sales and market approval for ARTAX, a paclitaxel eluting coronary stent, in the important and rapidly growing Indian healthcare market. ARTAX is a new developed Drug eluting Stent, which has an innovative polymer free Drug release system. Adverse effects, like inflammation and eventual allergic reactions due to the dissolving of the polymer are eliminated. This stent is indicated to being used for coronary arteries as well as for lesions below the knee. This gives the cardiologist a real alternative to Cordis, which produced so far the only drug eluting stent, which can be used in coronary as well as in peripheral locations. About Aachen Resonance: Aachen Resonance is a leading European manufacturer of medical technology with a worldwide market presence. The company offers a complete line of products for treatment, and advanced therapy support in vascular intervention, working in close collaboration with the University of Technology in Aachen, Germany. Its main focus is developing new devices with improved biocompatibility The field of vascular intervention consists of balloon catheters, stents, drug eluting stents and drug eluting balloons for coronary and peripheral applications. The company invests heavily in research and development, and is pursuing important, future-oriented approaches to cardiovascular therapy. Currently, Aachen Resonance maintains three headquarters in Europe for Aachen Resonance Entwicklungsgesellschaft für magnetresonanz-kompatible Medizinprodukte mbH Handelsregister:8455 Aachen
-
Upload
alexander001 -
Category
Documents
-
view
619 -
download
3
description
Aachen Resonance announces the sales and market approval for ARTAX, a paclitaxel eluting coronary stent, in the important and rapidly growing Indian healthcare market.
Transcript of Aachen Resonance enters the booming Indian Healthcare Market
Aachen Resonance GmbHPauwelsstrasse 19, 52074 Aachen, Tel. +49-(0)241-97900905, Fax +49-(0)241-97900907, E-Mail: [email protected]
Aachen, Germany, 07.01.2009
Aachen Resonance enters the booming Indian Healthcare Market with its new developed polymer-free Drug eluting Stent
Communication:
Aachen Resonance announces the sales and market approval for ARTAX, a paclitaxel eluting coronary stent, in the important and rapidly growing Indian healthcare market.
ARTAX is a new developed Drug eluting Stent, which has an innovative polymer free Drug release system. Adverse effects, like inflammation and eventual allergic reactions due to the dissolving of the polymer are eliminated.
This stent is indicated to being used for coronary arteries as well as for lesions below the knee. This gives the cardiologist a real alternative to Cordis, which produced so far the only drug eluting stent, which can be used in coronary as well as in peripheral locations.
About Aachen Resonance:
Aachen Resonance is a leading European manufacturer of medical technology with a worldwide market presence. The company offers a complete line of products for treatment, and advanced therapy support in vascular intervention, working in close collaboration with the University of Technology in Aachen, Germany.
Its main focus is developing new devices with improved biocompatibility
The field of vascular intervention consists of balloon catheters, stents, drug eluting stents and drug eluting balloons for coronary and peripheral applications.
The company invests heavily in research and development, and is pursuing important, future-oriented approaches to cardiovascular therapy. Currently, Aachen Resonance maintains three headquarters in Europe for research and development and manufacturing.
Aachen Resonance is market leader in Europe for Drug eluting balloons.
Contact address:
Dr. Alexander Ruebben, MBAChairman of the Aachen Resonance
Aachen Resonance GmbHPauwelsstrasse 19
Aachen Resonance Entwicklungsgesellschaft für magnetresonanz-kompatible Medizinprodukte mbHHandelsregister: 8455 Aachen
D-52074 Aachen Germany
Tel. 0049 241 97900905Fax. 0049 241 97900907www.aachen-resonance.comEmail: [email protected]
Marketing Director for ASIA:
Mr. Girish Rajeev
Adress: 713 Mangal Arambh, S.V Road, Borivilli
west, Mumbai 400 092. IndiaTel.: 91-9819724045
Aachen Resonance Entwicklungsgesellschaft für magnetresonanz-kompatible Medizinprodukte mbHHandelsregister: 8455 Aachen
![INDEX [assets.cambridge.org]Aachen and Lothar IV ofFrance and Ottonians , , , , , Aachen capitulary Aachen Gospels , , , ,](https://static.fdocuments.in/doc/165x107/60b8d200380fd66cca378262/index-aachen-and-lothar-iv-offrance-and-ottonians-aachen-capitulary.jpg)
